9 results
Jaundice Evaluation Algorithm #Diagnosis #Management #EM #IM #GI #Jaundice #Hyperbilirubinemia #Workup #Evaluation #Differential #Algorithm #Direct #Indirect
Jaundice Evaluation ... Algorithm #Diagnosis ... #Management #EM ... #IM #GI #Jaundice ... #Differential #Algorithm
Evaluation and Management of Gastrointestinal Bleeding #Diagnosis #Management #EM #GI #Bleed #UpperGI #LowerGI #Resuscitation #Differential #Algorithm
Evaluation and Management ... Diagnosis #Management #EM ... #GI #Bleed #UpperGI ... #Differential #Algorithm
Fatigue and IBD Algorithm
 • 40-50% patients have fatigue despite clinical remission
 • Risk factors: BMI,
Algorithm • 40- ... Pearls: • IDA ... differentiate IDA ... modifications Algorithm ... #Algorithm #diagnosis
Algorithm for managing the failure of anti-TNF therapy. ADA=anti-drug antibody; IM=immunomodulator; MOA=mechanism of action; TNF=tumor necrosis
Algorithm for managing ... ADA=anti-drug antibody ... factor #Management #GI ... #IM #IBD #AntiTNFFailure ... AntiDrugAntibodies #DrugLevels #Algorithm
Algorithm for the Evaluation of Dysphagia:Oropharyngeal:
- Characterized by difficulty initiating swallowing and accompanied by choking/coughing, nasopharyngeal
Algorithm for the ... Evaluation of Dysphagia ... #Differential #EM ... #GI #Dysphagia ... #Extraluminal #Algorithm
Vitamin B12 (Cobalamin) Deficiency
Etiology:
 • Vit B12 - aka cobalamin. Present in foods derived from animal
pernicious anemia, PA ... skin pallor • GI ... diarrhea related to IBD ... total body stores Evaluation ... symptoms • P/E - GI
UCSF COVID-19 Adult Clinical Evaluation Guide - Updated April 10 2020

Clinical Presentation
• Fever: hospitalized pts but
Adult Clinical Evaluation ... rhinorrhea) <20% • GI ... UCSF COVID-19 ID ... UCSF #COVID19 #Evaluation ... Guide #Diagnosis #Algorithm
Immune Checkpoint Inhibitor-Mediated Colitis
Grade of Disease Severity:
 • G1: Increase < 4 BMs/day over baseline; mild
indicated Diagnostic Evaluation ... -4 • Consult GI ... diagnosis #management #algorithm ... #IBD
Myelodysplastic syndromes current treatment algorithm 2018.

From Blood Cancer Journal, Published 24 May 2018

Myelodysplastic syndromes (MDS) are
current treatment algorithm ... risk of clonal evolution ... Administration (FDA ... since decitabine’s FDA ... #algorithm #hematology